PURPOSE: To assess the outcomes and analyze complication rates following primary iris claw IOL retrofixation with intravitreal @entity2995 . METHODS: This is a retrospective interventional case series. @entity1 with poor capsular support-diagnosed preoperatively or owing to intraoperative complications-were treated with iris claw IOL retrofixation with intravitreal @entity2995 . The data were retrospectively analyzed. RESULTS: 104 eyes of 102 @entity1 with poor capsular support who underwent the procedure between 2010 and 2013 were analyzed. The minimum follow-up period was 12  months (ranging from 12 to 36  months). Iris claw IOL was implanted in-traumatic subluxated @entity231 -24 cases (23.07%), non-traumatic subluxated @entity231 in 16 cases (15.38%), or as a complication of @entity231 surgery-intraoperative posterior capsular rent in 48 cases (46.15%) and intraoperative nucleus drop in 16 cases (15.38%). The final mean best-corrected logMAR visual acuity improved from 1.36      0.64 preoperatively to 0.36      0.32 at 1-year follow-up. Complications included pupil ovalization in 11 cases (10.57%), transient elevation in intraocular pressure in 7 eyes (6.73%), @entity86 in 5 eyes (4.80%), @entity1103 in 2 eyes (1.92%), @entity1713 in 1 eye (0.96%), @entity548 in 1 eye (0.96%), and @entity5891 in 1 eye (0.96%). CONCLUSION: Primary iris claw IOL retrofixation provided excellent alternative in @entity1 with inadequate capsular support. The visual outcomes were good along with favorable rates of complications. The addition of @entity2995 helps in reducing the chances of @entity1103 .

Primary iris claw IOL retrofixation with intravitreal XXXX in cases of inadequate capsular support.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity2995 :: ('MESH:D014222', 'Chemical') :: ['triamcinolone acetonide'] @entity231 :: ('MESH:D002386', 'Disease') :: ['cataracts', 'cataract'] @entity548 :: ('MESH:D006470', 'Disease') :: ['vitreous hemorrhage'] @entity1713 :: ('MESH:D012163', 'Disease') :: ['retinal detachment'] @entity1103 :: ('MESH:D008269', 'Disease') :: ['cystoid macular edema'] @entity86 :: ('MESH:D019106', 'Disease') :: ['postoperative hypotony'] @entity5891 :: ('MESH:D006988', 'Disease') :: ['hyphema']
@entity2995 :: (MESH:D014222,Chemical) :: ['triamcinolone acetonide']
